Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. The company is headquartered in Beijing, Beijing and currently employs 18 full-time employees. The firm focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The firm also offers stem cell related services including cell testing and health management consulting services.
How did YBGJ's recent EPS compare to expectations?
The most recent EPS for Yubo International Biotech Ltd is $, expectations of $.
How did Yubo International Biotech Ltd YBGJ's revenue perform in the last quarter?
Yubo International Biotech Ltd revenue for the last quarter is $
What is the revenue estimate for Yubo International Biotech Ltd?
According to of Wall street analyst, the revenue estimate of Yubo International Biotech Ltd range from $ to $
What's the earning quality score for Yubo International Biotech Ltd?
Yubo International Biotech Ltd has a earning quality score of B+/54.022205. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Yubo International Biotech Ltd report earnings?
Yubo International Biotech Ltd next earnings report is expected in
What are Yubo International Biotech Ltd's expected earnings?
Yubo International Biotech Ltd expected earnings is $, according to wall-street analysts.
Did Yubo International Biotech Ltd beat earnings expectations?
Yubo International Biotech Ltd recent earnings of $ expectations.